Erelzi vs. Eticovo

Are Erelzi and Eticovo the Same Thing?

Erelzi (etanercept-szzs) injection and Eticovo (etanercept-ykro) are tumor necrosis factor (TNF) blockers used to treat certain autoimmune disorders such as rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (JIA) in patients aged 2 years or older, psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (PsO).

Erelzi and Eticovo are biosimilar to Enbrel (etanercept).

Side effects of Erelzi and Eticovo that are similar include infections (such as upper respiratory infections, nasopharyngitis, sinusitis, and influenza), injection site reactions (redness, itching, pain, swelling, bleeding, bruising), diarrhea, rash, hives, and fever.

Both Erelzi and Eticovo may interact with live vaccines, anakinra, abatacept, and cyclophosphamide.

What Are Possible Side Effects of Erelzi?

Common side effects of Erelzi include:

  • infections,
  • injection site reactions (redness, itching, pain, swelling, bleeding, bruising),
  • diarrhea,
  • rash,
  • hives, and
  • fever.

What Are Possible Side Effects of Eticovo?

Common side effects of Eticovo include:

  • infections (such as upper respiratory infections, nasopharyngitis, sinusitis, and influenza),
  • injection site reactions,
  • diarrhea,
  • rash,
  • itching,
  • fever, and
  • hives

What is Erelzi?

Erelzi (etanercept-szzs) injection, for subcutaneous use is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (JIA) in patients aged 2 years or older, psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (PsO).

What is Eticovo?

Eticovo (etanercept-ykro) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (JIA) in patients aged 2 years or older, psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (PsO) in patients 4 years or older. Eticovo is biosimilar to Enbrel (etanercept).

SLIDESHOW

Types of Psoriasis: Medical Pictures and Treatments See Slideshow

What Drugs Interact With Erelzi?

Erelzi may interact with live vaccines, anakinra, abatacept, and cyclophosphamide. Tell your doctor all medications and supplements you use and all vaccines you recently received. Tell your doctor if you are pregnant or plan to become pregnant before using Erelzi. It is unknown if it would affects a fetus. Erelzi passes into breast milk but it is unknown if it would affect a nursing baby. Consult your doctor before breastfeeding.

What Drugs Interact With Eticovo?

Eticovo may interact with "live vaccines," anakinra, abatacept, and cyclophosphamide, and sulfasalazine. Tell your doctor all medications and supplements you use and all vaccines you recently received. Tell your doctor if you are pregnant or plan to become pregnant before using Eticovo; it is unknown how it would affect a fetus. Eticovo passes into breast milk in low levels. Consult your doctor before breastfeeding.

How Should Erelzi Be Taken?

The dose of Erelzi to treat adult RA and PsA is 50 mg once weekly with or without methotrexate; the dose of Erelzi to treat AS is 50 mg once weekly; the dose of Erelzi to treat adult PsO is 50 mg twice weekly for 3 months, followed by 50 mg once weekly; and the dose of Erelzi to treat JIA (patients who weigh >63 kg) is 0.8 mg/kg weekly, with a maximum of 50 mg per week.

How Should Eticovo Be Taken?

The dose of Eticovo to treat adult rheumatoid arthritis and psoriatic arthritis is 50 mg once weekly with or without methotrexate (MTX). The dose of Eticovo to treat ankylosing spondylitis is 50 mg once weekly. The dose of Eticovo to treat adult plaque psoriasis is 50 mg twice weekly for 3 months, followed by 50 mg once weekly. The dose of Eticovo to treat pediatric plaque psoriasis or plaque psoriasis (patients who weigh 63 kg or more) is 50 mg once weekly.

QUESTION

Psoriasis causes the top layer of skin cells to become inflamed and grow too quickly and flake off. See Answer
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Sandoz. Erelzi Product Information

https://www.erelzi.com/

FDA. Eticovo Prescribing Information.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf

Health Solutions From Our Sponsors